Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-220496
Abstract: We read with great interest the article by Geisen et al. The authors reported a considerable immunogenicity of mRNA vaccines against SARSCoV-2 in patients with chronic inflammatory diseases receiving immunosuppression; noteworthy, none was on Bcell… read more here.
Keywords: bcell; maintenance; sarscov; case ... See more keywords